Greg Russotti Email

CEO (ad interim) . Century Therapeutics

Current Roles

Employees:
343
Revenue:
$35.2M
About
Our genetically-engineered, universal iPSCs-derived immune effector cell products (NK, T, Dendritic cells, and macrophage) are designed to specifically target hematologic and solid tumor cancers. Our commitment to developing off-the-shelf cell therapies will expand patient access and provides an unparalleled opportunity to advance the course of cancer care.
Century Therapeutics Address
25 N. 38th Street
Philadelphia, PA
United States
Century Therapeutics Email

Past Companies

Century Therapeutics, IncChief Executive Officer (ad interim)
Century Therapeutics, LLCChief Technology Officer
CelgeneVice President, Cell Therapy Development and Operations